Jan 7 (Reuters) - AbbVie (ABBV.N), opens new tab on Wednesday denied it was in talks to buy Revolution Medicines (RVMD.O), opens new tab after the Wall Street Journal reported the drugmaker was in ...

AbbVie on Thursday denied that it is in talks to buy cancer-drug biotech Revolution Medicines, sending both stocks lower ahead of the opening bell.

July 30 (Reuters) - Drugmaker AbbVie (ABBV.N), opens new tab is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, ...

AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its blockbuster anti-wrinkle therapy Botox for the next round of Medicare price ...